A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
Clinical trial NCT00121836 · COMPLETED
Trial details
- NCT number
- NCT00121836
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2008-12-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.